Herantis Pharma Plc's Financial Statements Release January 1-December 31, 2016
Herantis Pharma Plc's Financial Statements Release January 1-December 31, 2016 Leading science from Finland in first-in-the-world clinical studies Highlights in January-December 2016: · The research and innovation program of the European Union, Horizon 2020, awarded in December a grant of approximately €6.0 million for Herantis' Phase 1-2 clinical study with CDNF for the treatment of Parkinson's disease. · The company announced in October a collaboration with the UK based device manufacturer Renishaw plc related to the clinical study in Parkinson's disease · Patient